Older Adult Health: Aging, Function, and Common Challenges

Aging is not a single event but a cascade of biological, psychological, and social shifts that accumulate over decades — and how that cascade unfolds varies enormously from one person to the next. This page examines how the body and mind change after age 65, what drives those changes, the health challenges most likely to emerge, and how clinicians and individuals distinguish normal aging from conditions that warrant intervention. The stakes are considerable: adults 65 and older represent roughly 17% of the U.S. population (U.S. Census Bureau) and account for a disproportionate share of hospitalizations, prescription drug use, and chronic disease burden.

Definition and scope

"Older adult health" refers to the physical, cognitive, and psychosocial dimensions of wellbeing in adults generally defined as age 65 and older, though geriatric medicine recognizes meaningful distinctions between the "young-old" (65–74), the "old-old" (75–84), and the "oldest-old" (85+). Each bracket carries different risk profiles, functional capacities, and clinical priorities.

The scope extends well beyond disease management. Geriatric health frameworks — including those used by the American Geriatrics Society — center on what clinicians call the "5 Ms": Mind, Mobility, Medications, what Matters Most to the patient, and Multicomplexity (the presence of multiple interacting conditions). That last element is worth pausing on: more than 60% of Medicare beneficiaries live with 2 or more chronic conditions simultaneously (Centers for Medicare & Medicaid Services), which means older adult health rarely fits the clean single-diagnosis model that dominates most clinical training.

This sits within the broader health across life stages framework, intersecting heavily with chronic disease, mental health, and musculoskeletal health.

How it works

Aging involves physiological changes that are universal, gradual, and — crucially — not the same as disease. The distinction matters clinically and personally.

Physiological changes by system:

1. Cardiovascular: Arterial walls stiffen, reducing elasticity; resting heart rate changes little, but maximum heart rate declines roughly 1 beat per minute per year of age. The heart's left ventricular wall thickens modestly.
2. Musculoskeletal: Sarcopenia — age-related loss of muscle mass — begins as early as the 4th decade but accelerates after 70. Bone mineral density declines in both sexes, more sharply in women post-menopause.
3. Neurological: Processing speed slows; working memory becomes less efficient. Structural MRI studies show gradual cortical thinning, particularly in prefrontal regions. These changes are not dementia.
4. Renal: Glomerular filtration rate declines approximately 1 mL/min/year after age 40 (National Institute on Aging), making drug dosing adjustments a near-universal clinical consideration.
5. Immune: Immunosenescence — the gradual decline in immune function — reduces vaccine response efficiency and increases susceptibility to infections and certain cancers.
6. Sensory: Presbyopia (near-vision loss) and presbycusis (high-frequency hearing loss) are nearly universal by the 7th decade.

What separates normal aging from pathology is largely a question of rate and function. A 78-year-old who takes slightly longer to recall a name is aging normally. One who cannot recognize family members is not. The dividing line is functional impairment — whether changes interfere with daily life.

Preventive health strategies, particularly physical activity and nutrition, demonstrably slow — though cannot stop — several of these trajectories.

Common scenarios

The clinical landscape for older adults clusters around a handful of high-frequency challenges:

Polypharmacy is among the most underappreciated. Adults 65 and older fill an average of 22 prescriptions per year (AARP Public Policy Institute), and drug-drug interactions rise nonlinearly with each additional medication. The Beers Criteria — published by the American Geriatrics Society — identifies specific drug classes that are potentially inappropriate for older adults, including certain sedatives, anticholinergics, and long-acting benzodiazepines.

Falls are not accidents in the way a younger person's stumble is. They are a clinical syndrome with identifiable risk factors: impaired gait, reduced lower-extremity strength, vision loss, orthostatic hypotension, and environmental hazards. The CDC reports that falls are the leading cause of injury death in adults 65 and older (CDC Injury Center).

Cognitive decline spans a wide spectrum — from the mild cognitive impairment that does not significantly disrupt daily function, to Alzheimer's disease and other dementias that eventually erode independence entirely. An estimated 6.9 million Americans age 65 and older are living with Alzheimer's dementia (Alzheimer's Association, 2024 Facts and Figures).

Social isolation functions as a genuine health risk factor, not merely an emotional hardship. The National Academies of Sciences, Engineering, and Medicine identified social isolation as associated with a 29% increased risk of cardiovascular disease and a 50% increased risk of developing dementia. Social health is not peripheral to aging — it operates as a determinant of longevity.

Decision boundaries

The hardest clinical and personal decisions in older adult health often involve distinguishing reversible problems from irreversible ones, and aggressive intervention from appropriate restraint.

Normal aging vs. clinical condition: Slower processing speed is normal; confusion about date, place, or person requires evaluation. Mild joint stiffness in the morning is common; pain that limits walking warrants imaging and functional assessment.

Screening thresholds shift with age. Cancer screening guidelines — for colorectal, breast, and prostate cancers — generally include upper age limits or discretionary zones, because screening benefit declines as life expectancy shortens and treatment burden grows. The U.S. Preventive Services Task Force (USPSTF) provides age-stratified recommendations that account for this explicitly.

Functional status over diagnosis: Geriatric medicine increasingly treats functional status — what a person can do — as the central metric, more than any single laboratory value or diagnosis. A 90-year-old with mild hypertension and excellent mobility may require less aggressive intervention than a 70-year-old with the same blood pressure reading but significant frailty.

Frailty vs. robust aging: Frailty is a measurable clinical syndrome defined by weight loss, exhaustion, low physical activity, slow gait speed, and weak grip strength — 3 or more of these 5 criteria, in the Fried Frailty Phenotype model, constitutes frailty. It predicts falls, hospitalization, and mortality independently of age and diagnosis, and it changes the risk-benefit calculation for surgery, chemotherapy, and other high-burden interventions.

Health risk factors accumulated across the life course — including tobacco use, chronic stress, and poor sleep — compress morbidity into later years rather than extending healthy function, which is why earlier-stage prevention carries such long downstream weight.